Champions Oncology, Inc.
NASDAQ:CSBR
Overview | Financials
Company Name | Champions Oncology, Inc. |
Symbol | CSBR |
Currency | USD |
Price | 10.74 |
Market Cap | 148,418,208 |
Dividend Yield | 0% |
52-week-range | 3.6 - 11.99 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Ronnie Morris M.D. |
Website | https://www.championsoncology.com |
An error occurred while fetching data.
About Champions Oncology, Inc.
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD